| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President and CEO | See Remarks
2 companies
Jonathan G Drachman last filed a Form 4 in August 2022, as Director at CALA. The filings on record cover 2 companies. Jonathan G Drachman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Jonathan G Drachman's trades have earned a below-average insider score of 15/100 across 4 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -85.6%.
At the last filing, the largest reported position was 25,000 shares of NGNE. Net of sales, the NGNE filings show accumulation of 569,047 shares.
Jonathan G Drachman has 17 Form 4 filings on record from June 2015 to August 2022, across 2 companies: President and CEO at Neurogene (NGNE), 2019–2022; Director at CALA, 2015–2021.
The 25 reported transactions were 11 option or other derivative awards, 10 open-market purchases, 2 conversions and 2 stock awards.
Counted by filing, the open-market trades come to 5 purchases worth about $3.4M and no sales.
The largest open-market purchase was 119,047 shares of NGNE at an average $8.40 on December 20, 2019, about $1.0M.
Shares as reported in the last Form 4 for each company; the most recent is from August 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2021 | Director | Buy | 200,000 | $0.86 | $171,900.00 | New | - | - | ||
| Aug 25, 2021 | NGNE Neurogene Inc. | President and CEO | Buy | 150,000 | $6.22 | $933,550.00 | -120.0% | -17.8% | -81.5% | |
| Jun 4, 2021 | NGNE Neurogene Inc. | President and CEO | Buy | 50,000 | $9.51 | $475,354.00 | +2.3% | -21.5% | -90.2% | |
| Dec 20, 2019 | NGNE Neurogene Inc. | President and CEO | Buy | 119,047 | $8.40 | $999,994.80 | +5.7% | - | - | |
| Sep 11, 2019 | NGNE Neurogene Inc. | See Remarks | Buy | 250,000 | $3.13 | $781,746.58 | +74.8% | - | - |